179 related articles for article (PubMed ID: 21625163)
1. The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy.
Kavanagh BD; Timmerman R; Meyer JL
Front Radiat Ther Oncol; 2011; 43():370-381. PubMed ID: 21625163
[TBL] [Abstract][Full Text] [Related]
2. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.
Sahgal A; Roberge D; Schellenberg D; Purdie TG; Swaminath A; Pantarotto J; Filion E; Gabos Z; Butler J; Letourneau D; Masucci GL; Mulroy L; Bezjak A; Dawson LA; Parliament M;
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):629-39. PubMed ID: 22633542
[TBL] [Abstract][Full Text] [Related]
3. Normal tissue toxicity after small field hypofractionated stereotactic body radiation.
Milano MT; Constine LS; Okunieff P
Radiat Oncol; 2008 Oct; 3():36. PubMed ID: 18976463
[TBL] [Abstract][Full Text] [Related]
4. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer.
Guckenberger M; Andratschke N; Dieckmann K; Hoogeman MS; Hoyer M; Hurkmans C; Tanadini-Lang S; Lartigau E; Méndez Romero A; Senan S; Verellen D
Radiother Oncol; 2017 Jul; 124(1):11-17. PubMed ID: 28687397
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery/stereotactic body radiation therapy-reflection on the last decade's achievements and future directions.
Knisely J; Sahgal A; Lo S; Ma L; Chang E
Ann Palliat Med; 2016 Apr; 5(2):139-44. PubMed ID: 27121742
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Timmerman R; Bastasch M; Saha D; Abdulrahman R; Hittson W; Story M
Front Radiat Ther Oncol; 2011; 43():382-394. PubMed ID: 21625164
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
8. Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy.
Ponti E; Lancia A; Ost P; Trippa F; Triggiani L; Detti B; Ingrosso G
Eur Urol Focus; 2017 Dec; 3(6):538-544. PubMed ID: 28801240
[TBL] [Abstract][Full Text] [Related]
9. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
[TBL] [Abstract][Full Text] [Related]
10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.
Videtic GMM; Donington J; Giuliani M; Heinzerling J; Karas TZ; Kelsey CR; Lally BE; Latzka K; Lo SS; Moghanaki D; Movsas B; Rimner A; Roach M; Rodrigues G; Shirvani SM; Simone CB; Timmerman R; Daly ME
Pract Radiat Oncol; 2017; 7(5):295-301. PubMed ID: 28596092
[TBL] [Abstract][Full Text] [Related]
12. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.
Timmerman R; Galvin J; Michalski J; Straube W; Ibbott G; Martin E; Abdulrahman R; Swann S; Fowler J; Choy H
Acta Oncol; 2006; 45(7):779-86. PubMed ID: 16982540
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
14. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
Tubin S; Popper HH; Brcic L
Radiat Oncol; 2019 Jan; 14(1):21. PubMed ID: 30696472
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for prostate cancer-a review.
Haque W; Butler EB; Teh BS
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S10. PubMed ID: 28917248
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
[TBL] [Abstract][Full Text] [Related]
17. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
[TBL] [Abstract][Full Text] [Related]
18. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A
J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628
[TBL] [Abstract][Full Text] [Related]
19. Myositis following spine radiosurgery for metastatic disease: a case series.
Lockney DT; Jia AY; Lis E; Lockney NA; Liu C; Hopkins B; Higginson DS; Yamada Y; Laufer I; Bilsky M; Schmitt AM
J Neurosurg Spine; 2018 Apr; 28(4):416-421. PubMed ID: 29372858
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
Oermann EK; Slack RS; Hanscom HN; Lei S; Suy S; Park HU; Kim JS; Sherer BA; Collins BT; Satinsky AN; Harter KW; Batipps GP; Constantinople NL; Dejter SW; Maxted WC; Regan JB; Pahira JJ; McGeagh KG; Jha RC; Dawson NA; Dritschilo A; Lynch JH; Collins SP
Technol Cancer Res Treat; 2010 Oct; 9(5):453-62. PubMed ID: 20815416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
